BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28467776)

  • 1. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
    An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
    Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.
    Yang Y; Song S; Meng Q; Wang L; Li X; Xie S; Chen Y; Jiang X; Wang C; Lu Y; Xin X; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
    J Cell Mol Med; 2020 Mar; 24(5):2772-2790. PubMed ID: 32030886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.
    Lin Z; Lu Y; Meng Q; Wang C; Li X; Yang Y; Xin X; Zheng Q; Xu J; Gui X; Li T; Pu H; Xiong W; Li J; Jia S; Lu D
    Mol Ther Nucleic Acids; 2018 Jun; 11():494-507. PubMed ID: 29858084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
    Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
    Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.
    Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W
    Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284
    [No Abstract]   [Full Text] [Related]  

  • 9. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
    J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p.
    Li Y; Wang Y; Xie Z; Hu H
    Mol Med Rep; 2019 Apr; 19(4):2489-2496. PubMed ID: 30720092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
    Xu W; Jiang K; Shen M; Chen Y; Huang HY
    Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
    Kim TD; Shin S; Berry WL; Oh S; Janknecht R
    J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
    Sheng G; Bernabe KQ; Guo J; Warner BW
    Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.
    Zurlo D; Leone C; Assante G; Salzano S; Renzone G; Scaloni A; Foresta C; Colantuoni V; Lupo A
    Mol Carcinog; 2013 Jan; 52(1):1-17. PubMed ID: 22025467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
    Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
    Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
    Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
    Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.